✦ LIBER ✦

High-dose cisplatin for locally advanced or metastatic head and neck cancer. A phase ii pilot study

✍ Scribed by Kathleen A. Havlin; John G. Kuhn; J. William Myers; Robert F. Ozols; Douglas E. Mattox; Gary M. Clark; Daniel D. Von Hoff

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 484 KB
Volume: 63
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19890201)63:3<423::aid-cncr2820630304>3.0.co;2-c

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of cisplatin and contin

A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancer

✍ Eduardo Tellez-Bernal; Gonzalo Recondo; Thierry Guillot; Mohamed Benhamed; Chris 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB 👁 2 views

The chemotherapeutic treatment of recurrent and/or metastatic squamous cell carcinoma (SCC) of the head and neck (H & N) has a very dismal prognosis, with survival usually not exceeding 1 year. Reported objective response rates vary between 3% and 70%. This difference appears largely attributable to

High-dose intra-arterial cisplatin and c

High-dose intra-arterial cisplatin and concurrent hyperfractionated radiation therapy in patients with locally advanced primary squamous cell carcinoma of the head and neck: Report of a phase II study

✍ William F. Regine; Joseph Valentino; William John; Gayle Storey; David Sloan; Da 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

Ifosfamide, cisplatin, and 13-Cis retino

Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck : A Phase I–II study

✍ Francesco Recchia; Angelo Lalli; Marco Lombardo; Sandro De Filippis; Gaetano Sag 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

A phase II trial of cisplatin, methotrex

A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck

✍ Francesco Caponigro; Pasquale Comella; Paolo Marcolin; Francesco Russo Spena; Ma 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Background: Induction chemotherapy in locoregionally advanced squamous cell carcinoma of the head and neck (scchn) might improve survival with respect to radiation therapy alone. furthermore, chemotherapy represents the only therapeutic option in metastatic head and neck carcinoma. ## Methods:

Phase II evaluation of cisplatin and eto

Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma : A Southwest Oncology Group study

✍ Stephen K. Williamson; Danika Lew; Gary J. Miller; Stanley P. Balcerzak; Laurenc 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

## Background: A previous southwest oncology group study demonstrated a 30% response rate with the combination of cisplatin and mitotane in the treatment of patients with metastatic adrenocortical carcinoma. several case reports suggested that the combination of etoposide and cisplatin may be an ac